HARRELL INVESTMENT PARTNERS, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1802882
AUSTIN, TX
Position in REGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,302,575
-$290,608 QoQ
Shares Held
2,089
+1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#599
of 1,322 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARRELL INVESTMENT PARTNERS, LLC holds $3,495,637 across 2 Biotechnology names. REGN ranks #2 (37.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,415 | $2,193,062 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,089 | $1,302,575 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,302,575 | 2,089 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,593,183 | 2,062 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,603,945 | 2,078 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,169,521 | 2,080 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,055,250 | 2,010 | Shares | Sole | 2025-07-15 | |
| No filing history on record for this holder in this stock. | ||||||